XML 21 R5.htm IDEA: XBRL DOCUMENT  v2.3.0.11
STATEMENTS OF CASH FLOWS (USD $)
6 Months Ended 102 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Cash flows from operating activities      
Net loss $ (2,794,161) $ (3,243,477) $ (97,506,500)
Adjustments to reconcile net loss to net cash used in operating activities:      
Stock payable for acquired research and development     112,440
Stock issued for acquired research and development     26,286,589
Stock issued for services 87,028   2,061,743
Stock issued for debt in excess of principal     109,070
Amortization of discount on notes payable due to warrants and beneficial conversion feature   314,749 6,752,698
Gain on extinguishment of debt     (1,612,440)
Depreciation 100,366 98,375 1,236,595
Amortization of debt financing costs   108,116 524,378
Option expense 291,873 305,294 15,377,166
Loss on derivative instruments     (1,388,848)
Loss on disposal of assets     500,562
Changes in:      
Other current assets (34,094) (14,857) (536,292)
Accounts payable - third parties and related parties 100,534 (118,218) 24,321
Accrued expenses (97,806) 183,204 189,491
Net cash used in operating activities (2,346,260) (2,366,814) (47,869,027)
Cash flows from investing activities      
Purchase of property & equipment (172,150)   (1,547,011)
Net cash used in investing activities (172,150)   (1,547,011)
Cash flows from financing activities      
Common stock and warrants sold for cash, net of offering costs 8,618,157   49,072,488
Common stock repurchased and canceled     (325)
Proceeds from exercise of warrants and options   92,868 1,248,588
Proceeds from debt     9,283,184
Repayments on notes payable (35,607) (33,022) (311,222)
Net cash provided by financing activities 8,582,550 59,846 59,292,713
Net change in cash and cash equivalents 6,064,140 (2,306,968) 9,876,675
Cash and cash equivalents at beginning of period 3,812,535 8,181,582  
Cash and cash equivalents at end of period 9,876,675 5,874,614 9,876,675
Cash paid for:      
Income tax      
Interest 2,005 83,040 152,033
NON-CASH TRANSACTIONS      
Issuance of common stock to Sportan shareholders     147,733
Issuance of common stock for accrued interest   78,091 603,604
Issuance of warrants to placement agent     37,453
Conversion of notes payable to common stock   1,302,000 7,709,980
Conversion of accrued liabilities to common stock     197,176
Conversion of accounts payable to note payable     93,364
Discount on convertible notes relating to:      
Warrants     3,659,737
Beneficial conversion feature     1,805,519
Stock attached to notes     1,287,440
Fair value of derivative instrument     4,680,220
Derivative reclassified to equity     587,609
Unpaid additions to property and equipment $ 42,399   $ 42,399